Ablaze Pharmaceuticals Funding: $75M Raised, Series A (2021)

Ablaze Pharmaceuticals funding overview

Ablaze Pharmaceuticals is based in Shanghai, China. Ablaze Pharmaceuticals has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2021. The round record for Ablaze Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Vivo Capital, AdvanTech Capital, RAYZ Investments, Nan Fung Life Sciences, Pivotal bioVenture Partners China, venBio Partners and 2 others. 8 distinct backers are named across the disclosed rounds.

Ablaze Pharmaceuticals at a glance

Total raised: $75M
Latest round: Series A
Latest round date: November 2021
Headquarters: Shanghai, China
Notable investors: Vivo Capital, AdvanTech Capital, RAYZ Investments, Nan Fung Life Sciences, Pivotal bioVenture Partners China, venBio Partners, Samsara BioCapital, Venrock Healthcare Capital Partners

Frequently asked about Ablaze Pharmaceuticals funding

How much has Ablaze Pharmaceuticals raised?: Ablaze Pharmaceuticals has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Ablaze Pharmaceuticals?: Vivo Capital, AdvanTech Capital, RAYZ Investments, Nan Fung Life Sciences, Pivotal bioVenture Partners China, venBio Partners are named among the investors backing Ablaze Pharmaceuticals.
What was the latest Ablaze Pharmaceuticals funding round?: The most recent disclosed round is a Series A, announced in November 2021.
Where is Ablaze Pharmaceuticals based?: Ablaze Pharmaceuticals is based in Shanghai, China.
When did Ablaze Pharmaceuticals last raise?: The last disclosed Ablaze Pharmaceuticals round closed in November 2021 at Series A.

Every Ablaze Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.

Ablaze Pharmaceuticals Funding: $75M Raised, Series A (2021)

Ablaze Pharmaceuticals funding overview

Ablaze Pharmaceuticals at a glance

Frequently asked about Ablaze Pharmaceuticals funding

Companies related to Ablaze Pharmaceuticals (36)

Browse related funding lists (7)